Stockscreener 앱 받기
12.41
2.06%
0.25
시간 외 거래:
12.32
-0.09
-0.73%
전일 마감가:
$12.16
열려 있는:
$11.98
하루 거래량:
142.19K
Relative Volume:
2.60
시가총액:
$264.18M
수익:
-
순이익/손실:
-
주가수익비율:
-0.4142
EPS:
-29.96
순현금흐름:
-
1주 성능:
-12.91%
1개월 성능:
+885.00%
6개월 성능:
+885.00%
1년 성능:
+885.00%
1일 변동 폭
$11.98
$12.76
1주일 범위
$11.75
$14.65
52주 변동 폭
$11.75
$17.94
Shoulder Innovations Inc Stock (SI) Company Profile
SI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SI
Shoulder Innovations Inc
|
12.41 | 264.18M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
134.28 | 227.88B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.14 | 152.55B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
377.58 | 143.34B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.88 | 114.49B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.35 | 46.11B | 5.69B | 4.14B | 577.90M | 6.96 |
Shoulder Innovations Inc Stock (SI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-03-06 | 다운그레이드 | Compass Point | Neutral → Sell |
| 2023-03-06 | 다운그레이드 | Wedbush | Neutral → Underperform |
| 2023-03-02 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2023-03-02 | 다운그레이드 | Compass Point | Buy → Neutral |
| 2023-03-02 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-03-01 | 다운그레이드 | Keefe Bruyette | Outperform → Mkt Perform |
| 2023-01-09 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2023-01-06 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-01-06 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2023-01-06 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-12-12 | 재확인 | Wedbush | Outperform |
| 2022-12-05 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2022-11-21 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-11-10 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-10-26 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-10-06 | 다운그레이드 | Wells Fargo | Overweight → Underweight |
| 2022-08-04 | 개시 | BTIG Research | Buy |
| 2022-06-13 | 개시 | Wells Fargo | Overweight |
| 2022-06-09 | 재개 | Morgan Stanley | Equal-Weight |
| 2022-03-21 | 개시 | BofA Securities | Buy |
| 2022-01-20 | 업그레이드 | Goldman | Neutral → Buy |
| 2021-12-16 | 개시 | B. Riley Securities | Buy |
| 2021-11-11 | 개시 | JP Morgan | Overweight |
| 2021-11-08 | 다운그레이드 | Keefe Bruyette | Outperform → Mkt Perform |
| 2021-09-27 | 개시 | Morgan Stanley | Overweight |
| 2021-06-14 | 개시 | Goldman | Neutral |
| 2021-01-14 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2020-12-22 | 개시 | Wedbush | Outperform |
| 2020-12-17 | 업그레이드 | Keefe Bruyette | Mkt Perform → Outperform |
| 2020-12-02 | 개시 | Craig Hallum | Buy |
| 2020-10-16 | 개시 | Compass Point | Buy |
| 2020-03-16 | 개시 | Canaccord Genuity | Buy |
| 2019-12-03 | 개시 | Keefe Bruyette | Mkt Perform |
| 2019-12-02 | 개시 | Barclays | Overweight |
| 2019-11-18 | 개시 | Compass Point | Buy |
모두보기
Shoulder Innovations Inc 주식(SI)의 최신 뉴스
Med-tech funding rebounds modestly to $18B through July - BioWorld MedTech
Medical Tech Firm Heartflow Jumps 51% After $317 Million IPO - Bloomberg.com
Medical Tech Firm Heartflow Surges 66% After $317 Million IPO - Bloomberg.com
Medical Tech Firm Heartflow Prices $317 Million IPO Above Range - Bloomberg.com
Shoulder Innovations Stock Jumps 8% On NYSE Debut - MSN
Medical Tech Firm Heartflow Raises IPO Target to $300 Million - Bloomberg.com
Gilde healthcare buys $1.5 million in shoulder innovations (SI) By Investing.com - Investing.com Australia
Gilde healthcare buys $1.5 million in shoulder innovations (SI) - Investing.com
Major Stakeholders Make Bold Moves in Shoulder Innovations, Inc. - TipRanks
U.S. IPO Weekly Recap: Figma Smashes Circle’s Record For Best Billion-Dollar IPO Pop - Seeking Alpha
Heartflow prices IPO, Shoulder Innovation joins NYSE - BioWorld MedTech
Shoulder Innovations: Interesting, Not Convinced (NYSE:SI) - Seeking Alpha
Shoulder Innovations falls short of IPO target with $75M raise - Crain's Grand Rapids Business
NYSE Content Advisory: Pre-market update + Figma valued at over $19 billion in IPO - The Malaysian Reserve
Latham & Watkins Advises Shoulder Innovations in Initial Public Offering - Latham & Watkins LLP
Shoulder Innovations announces pricing of IPO - Medical Buyer
Figma Surges in IPO, Valued at Over $19 Billion - AInvest
NYSE Content Advisory: Pre-market update + Figma valued at over $19 billion in IPO – Company Announcement - Financial Times
Shoulder Innovations Announces Pricing of Initial Public Offering - PR Newswire
Medtech IPOs Spur Talk of Broader US Health-Care Listing Revival - MSN
Shoulder Innovations is an IPO to watch, this analyst says - Cantech Letter
Grand Rapids device maker plans $105M IPO as implant sales surge - Crain's Grand Rapids Business
Del. Judge Denies $89M Claim In Silvergate Ch. 11 - Law360
US Life Sciences IPOs Revive with Medtech Companies Leading the Way - AInvest
Shoulder Innovations, Inc. (SI): Small MedTech Implant Company Gaining IPO Interest - Smartkarma
These innovations are transforming shoulder replacement surgery for optimal recovery. - thegazette.com
SHOULDER INNOVATIONS, INC. Plans $100 Million IPO for July 31st (SI) - Defense World
Pro Deals: 👩⚕️ Health Tech weekly - Axios
Shoulder Innovations Primes $100M IPO Amid Medtech Surge - Law360
Shoulder Innovations, Inc. (SI): Another MedTech to Test the Market, Sets Terms for July 31 IPO - Smartkarma
Shoulder Innovations Seeks $105M in U.S. IPO, Revenue Up 40% - AInvest
Shoulder Innovations Files for 5M Share IPO at $19-$21/sh - Investing.com Canada
Shoulder Innovations Announces Closing of a $40 Million Convertible Notes Financing - PR Newswire
Silvergate Capital (NYSE:SI) Trading Up 25% – Still a Buy? - Defense World
SEC Charges Alan Lane & Kathleen Fraher - stl.news
U.S. IPO Weekly Recap: 6 Small Listings Hit Market As Sizable IPOs Join The Pipeline - Seeking Alpha
Shoulder Innovations Begins IPO Effort For Commercialization Plans (Pending:SI) - Seeking Alpha
Cohen Milstein Sellers & Toll PLLC and Bernstein Litowitz Berger & Grossmann LLP Announce Pendency and Proposed Settlement of Class Action Involving All Persons and Entities who Purchased or Otherwise Acquired the Publicly Traded Common Stock a - ETX View
Venture-Backed MedTech Firm Shoulder Innovations Files IPO - Law360
SI IPO NewsShoulder surgery-focused medtech Shoulder Innovations files for a $100 million IPO - renaissancecapital.com
Silvergate Announces Virtual Participation at Canaccord’s 40th Annual Growth Conference - Business Wire
Bioretec Oy's Oversubscribed Rights Issue Fuels Ambitious Growth in Orthopedic Innovations - AInvest
Silvergate Capital $37.5M Securities Class Action Settlement - Claim Depot
Head to Head Contrast: Silvergate Capital (NYSE:SI) and RBB Bancorp (NASDAQ:RBB) - Defense World
Fed board issues order to Silvergate Bank as part of self-liquidation plan - PANews
Silvergate Estate To Chip In For $37.5M Investor Settlement - Law360
Head-To-Head Survey: Silvergate Capital (NYSE:SI) & Citizens & Northern (NASDAQ:CZNC) - Defense World
Variability in ultimate humeral height of an inlay humeral stem does not impact outcomes following reverse shoulder arthroplasty - ScienceDirect.com
Silvergate Gets Pause To Examiner Fight After Investor Deal - Law360
Silvergate ($SICPQ) Is Paying a Settlement to Investors — Here’s How to Get Your Share - TradingView
Silvergate Capital Director Defends Legitimacy of Board Probe - Bloomberg Law News
Shoulder Innovations Inc (SI) 재무 분석
Shoulder Innovations Inc (SI)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.17%
자본화:
|
볼륨(24시간):